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Background: Several studies have demonstrated a high diagnostic accuracy of coronary computed tomography angiography (CCTA) for detection 
of obstructive coronary artery disease (CAD) and predicting cardiac events in patients with intermediate risk for CAD, but the predictive value of CCTA 
in asymptomatic patients is unclear.
Methods: We analyzed 451 consecutive asymptomatic patients undergoing CCTA between December 2003 and November 2007. The primary 
endpoint of the study was the occurrence of cardiac events defined as cardiac death, nonfatal myocardial infarction, unstable angina requiring 
hospitalization and late revascularization (>90 days after CCTA) during a median follow-up of 27.5 months.
Results: 229 patients (54%) had nonobstructive coronary lesions and 107 patients (24%) obstructive CAD. During follow-up, 2 patients presented 
with unstable angina and 5 with stable angina requiring revascularization. Patients with obstructive CAD had a significantly higher event rate than 
those without obstructive CAD (risk ratio 9.4, 95% confidence interval 2.5 to 35.5, p<0.001 see also Figure below). In 217 patients (48%) the 
clinically assessed cardiovascular risk could be reclassified by CCTA from intermediate or high to low risk.
Conclusions: Although the event rate is low in asymptomatic patients, CCTA can reliably predict further cardiac events and reclassify two third of 
the patients regarding their cardiovascular risk.
